Three to ten years after cessation of therapy in children with leukemia.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001932:Brain Neoplasms / Q000517:prevention & control; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000473:pathology / Q000628:therapy*; D008218:Lymphocytosis / Q000473:pathology; D008297:Male; D011379:Prognosis; D012008:Recurrence; D012075:Remission, Spontaneous; D013120:Spinal Cord Neoplasms / Q000517:prevention & control; D013736:Testicular Neoplasms / Q000628:therapy; D013997:Time Factors
D000970:Antineoplastic Agents